DEXCOM, INC. Deferred Revenue Recognized
DEXCOM, INC. (DXCM) reported Deferred Revenue Recognized of $1.00 million for the 3-month period ending 2020-09-30, per its 10-Q filed 2020-10-27.
Discontinued › Income Statement › Other Income
us-gaap:ContractWithCustomerLiabilityRevenueRecognized · last filed 2020-10-27
- DEXCOM, INC. contract with customer, liability, revenue recognized for the quarter ending 2020-09-30 was $1.00M, a 65.52% decline year-over-year.
- DEXCOM, INC. contract with customer, liability, revenue recognized for the quarter ending 2020-06-30 was $800.00K, a 60.00% decline year-over-year.
- DEXCOM, INC. contract with customer, liability, revenue recognized for the quarter ending 2020-03-31 was $1.10M, a 54.17% decline year-over-year.
- DEXCOM, INC. contract with customer, liability, revenue recognized for the quarter ending 2019-09-30 was $2.90M, a 42.00% decline year-over-year.
- DEXCOM, INC. contract with customer, liability, revenue recognized for fiscal 2019 was $2.60M, a 36.84% increase from fiscal 2018.
- DEXCOM, INC. contract with customer, liability, revenue recognized for fiscal 2018 was $1.90M.
| Period end | Contract with Customer, Liability, Revenue Recognized 3 month | Contract with Customer, Liability, Revenue Recognized 6 month | Contract with Customer, Liability, Revenue Recognized 9 month | Contract with Customer, Liability, Revenue Recognized 12 month |
|---|---|---|---|---|
| 2020-09-30 | $1.00M 10-Q · filed 2020-10-27 | $1.80M 10-Q · filed 2020-10-27 | ||
| 2020-06-30 | $800.00K 10-Q · filed 2020-07-28 | $1.30M 10-Q · filed 2020-07-28 | ||
| 2020-03-31 | $1.10M 10-Q · filed 2020-04-28 | |||
| 2019-12-31 | $2.60M 10-K · filed 2020-02-13 | |||
| 2019-09-30 | $2.90M 10-Q · filed 2020-10-27 | $2.60M 10-Q · filed 2020-10-27 | ||
| 2019-06-30 | $2.00M 10-Q · filed 2020-07-28 | $2.60M 10-Q · filed 2020-07-28 | ||
| 2019-03-31 | $2.40M 10-Q · filed 2020-04-28 | |||
| 2018-12-31 | $1.90M 10-K · filed 2020-02-13 | |||
| 2018-09-30 | $5.00M 10-Q · filed 2019-11-06 | $1.90M 10-Q · filed 2019-11-06 | ||
| 2018-06-30 | $2.00M 10-Q · filed 2019-07-31 | $1.90M 10-Q · filed 2019-07-31 | ||
| 2018-03-31 | $1.50M 10-Q · filed 2019-05-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| BECTON DICKINSON & CO (BDX) | United States | $48.834B | 43.79 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |